Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivabradine dosing in paediatric dilated cardiomyopathy with chronic heart failure
2011-001292-39Phase 2Completed
- Sponsor
- Servier
- Start
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in dilated cardiomyopathy (DCM) and chronic heart failure (CHF) comparing Ivabradine with Placebo (2 arms). Primary endpoint: Primary pharmacokinetic and PK/PD characterization. Started Aug 2011; status: completed.
02
Drugs
ivabradine
03
Conditions
dilated cardiomyopathy (DCM)chronic heart failure (CHF)
Beyond the preview
Go deeper on 2011-001292-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001292-39.